Caplight Directory>Investors>UCB Ventures>Ucbventures


UCB Ventures

UCB Ventures

—ucbventures.com

Overview

UCB Ventures is a €150 million strategic corporate venture fund established in 2017 by UCB, a global biopharmaceutical company focused on neurology and immunology disorders. The fund invests in early-stage companies in the US and Europe, focusing on novel therapeutic modalities, platforms and assets that address novel biology .

Year Founded

2017

Portfolio Companies

13

Investments

CompanyDateStageLead
Splice BioJun 2025Series B-
Neurona TherapeuticsApr 2025Early Funding-
Rinri TherapeuticsJan 2025Series ACo-investor
Neurona TherapeuticsFeb 2024Series E-
ViaNautis BioNov 2023Series ALead
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

Headquarters—
Year Founded2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.